STATEMENT OF BENEFICIAL OWNERSHIP

Company

Celldex Therapeutics, Inc.

Filed

October 1, 1999

Accession Number

0000914121-99-000887

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →